Consultation Process. (a) Unless the expedited process in clause 3.4 applies, the Operator must follow the process set out below for consulting on a proposal to amend this agreement.
(b) The notice to be published under clause 3.2(b)(ii) must invite Members and other interested persons to submit written comments on the proposal to the Operator on or before a date specified in the notice (which must be at least 20 Business Days after the date of the notice).
(c) If the Operator considers it appropriate having regard to issues raised in submissions, it may undertake further consultation on specified issues or alternative proposals, and the notice and minimum time periods in paragraph (b) apply to that further consultation.
(d) The Operator must publish its decision on the proposal on its website within 20 Business Days after the closing date for submissions under paragraph (b) or (d) as applicable. The decision must:
(i) summarise any comments received on the proposal;
(ii) set out the proposed amendment to be made (if any);
(iii) if the proposed amendment is materially different from the original proposal, describe how and why the proposal has been revised;
(iv) if the decision is to make a proposed amendment then specify the day on which the amendment is to take effect; and
(v) if the decision is against making any proposed amendment, state that the proposal has been rejected and give reasons for the rejection.
(e) At least 15 Business Days before the day on which any amendment is to take effect, or an earlier date fixed by this agreement in any particular case, the Operator must:
(i) notify all Members and the AER of the amendment; and
(ii) publish the amendment and the amended Exchange Agreement on its website.
(f) In determining whether or not to make an amendment under this provision, the Operator must take into account all relevant and material comments that it receives by the closing date for comments and may take into account any comments it receives after that date.
Consultation Process. (1) If the Secretary considers that an employee is likely to become an excess employee, the Secretary must tell the employee in writing as soon as practicable, and give the employee written reasons why the employee is likely to become excess.
(2) The Secretary must discuss with the employee measures that might be taken to resolve the employee’s potentially excess status, including:
(a) redeployment opportunities for the employee at or below the employee’s existing level; and
(b) referral to career advisory services; and
(c) whether voluntary redundancy might be appropriate.
(3) If the employee nominates a representative, the Secretary must hold the discussions with the employee’s representative.
(4) Before the discussions are over, the Secretary may ask an employee who is not an excess employee to express interest in voluntary redundancy if that would permit the redeployment of an employee who is excess and would otherwise be subject to redundancy.
(5) The Secretary may identify an employee who is excess to the Department’s requirements:
(a) after the discussions under subclause (2) have been held; or
(b) if the employee or the employee’s representative declines to attend discussions – no less than 1 month after the Secretary has told the employee that the employee is likely to become an excess employee.
(6) After identifying an excess employee, the Secretary must tell the employee in writing that the employee is excess.
(7) The Secretary must establish, through consultation with identified employees, the employees who want to be offered voluntary redundancy immediately and the employees who seek redeployment.
(8) The Secretary must, in writing, tell an employee seeking redeployment that the employee is excess (if this has not already happened) and that the employee may, at their request, be referred to career advisory services.
(9) The Secretary must take reasonable steps, consistent with the interests of the efficient administration of the Department, to transfer an excess employee to a suitable vacancy at the same level within the Department.
(10) Despite subclauses (2) to (9), if an AGS employee is told in writing the employee is likely to become excess under subclause (1), the employee may, with the approval of the Secretary, fast-track the redundancy process. In these circumstances, the employee may decide to take a voluntary redundancy effective no later than 2 weeks after the written advice they are likely to become excess.
(11) Where an employee t...
Consultation Process. (a) At the time of providing written notice of reduction to affected Employee(s), the Employer shall:
(i) provide an affected Employee with the seniority lists set out in Article 9.04(a); and
(ii) schedule a consultation meeting between the affected Employee, the Employer and the Union, at which time the Employer shall advise the Employee of their retention options according to this Article, provided the Employee has the requisite job-related skills, training, knowledge and other relevant attributes to perform the work required in the retention options.
(b) The consultation meeting will not be unreasonably delayed as a result of the unavailability of a Union Representative.
Consultation Process. The primary vehicle for the Consultations referred to in this Article 4 will be the Physician Services Committee.
Consultation Process.
(a) The Employer shall notify the Union in writing, not less than 60 days prior to affecting any proposed labour adjustment initiative that could impact a significant number of employees, in accordance with Section 54 of the BC Labour Relations Code.
(b) A consultation committee of two employer and two union representatives will meet within seven days of the written notice in (a) above. The Committee will be mandated to address the requirements of Section 54 of the Labour Relations Code, make recommendations to the parties based on the provisions of the collective agreement and the Code, and participate in the implementation of Article 11 - Job Security, Layoff and Recall. The Committee will meet as necessary to carry out its mandate. One of the union appointees to the Committee will be from the bargaining unit and on employer paid leave in order to assist the Union in this consultation process.
(c) The parties agree to consider voluntary solutions to problems and adjustments which arise from downsizing and restructuring. The parties will endeavour to achieve them through permanent or interim solutions, where practicable. Voluntary options considered will include, but not be limited to, early retirement incentives, voluntary layoff, retraining, temporary assignments and relocations. Voluntary options agreed to during the consultation process will be offered to the employees identified during this process.
(d) If the parties do not agree to voluntary solutions, positions to be made redundant will be identified by the Employer. Notice of layoff will be made in accordance with the terms of the collective agreement.
Consultation Process. (i) In the event the Trustees are required to consult with the TAC pursuant to Section 2.2(e) above or on other matters as provided herein, the Trustees shall provide the TAC with written advance notice of the matter under consideration and, subject to reasonable claims of privilege, with as much relevant information concerning the matter as is reasonably practicable under the circumstances. The Trustees shall also provide the TAC with such reasonable access to experts retained by the PI Trust and its staff (if any) as the TAC may reasonably request during the time that the Trustees are considering such matter, and shall also provide the TAC the opportunity, at reasonable times and for reasonable periods of time, to discuss and comment on such matter with the Trustees.
(ii) The Trustees shall take into consideration the time required for the TAC, if its members so wish, to engage and consult with its own independent financial or investment advisors as to such matter.
Consultation Process. (i) In the event the Trustee is required to consult with the OAC pursuant to Section 2.2(e) above or on other matters as provided herein, the Trustee shall provide the OAC with written advance notice of the matter under consideration, and with all relevant information concerning the matter as is reasonably practicable under the circumstances. The Trustee shall also provide the OAC with such reasonable access to the Trust Professionals and other experts retained by the PSAN PI/WD Trust and its staff (if any) as the OAC may reasonably request during the time that the Trustee is considering such matter, and shall also provide the OAC the opportunity, at reasonable times and for reasonable periods of time, to discuss and comment on such matter with the Trustee.
(ii) In determining when to take definitive action on any matter subject to the consultation procedures set forth in this Section 6.7(a), the Trustee shall take into consideration the time required for the OAC, if its members so wish, to engage and consult with its own independent advisors as to such matter. In any event, the Trustee shall not take definitive action on any such matter until at least thirty (30) days after providing the OAC with the initial written notice that such matter is under consideration by the Trustee, unless such time period is waived in writing by the OAC or at a meeting where the OAC and Trustee are present.
Consultation Process. (a) At the time of providing written notice of Xxxxxx to affected Employee(s), the Employer shall:
(i) provide an affected Employee with the seniority lists set out in clause 9.04; and
(ii) provide an affected Employee with the list of current vacancies at the site; and
(iii) schedule a consultation meeting between the affected Employee, the Employer and the Union, at which time the Employer and the Union shall advise the Employee of their options according to clauses 27.05, 27.06, 27.07, and 27.08.
(b) When an Employee is on an approved leave of absence, or Workers’ Compensation Benefits, or Long Term Disability Insurance Benefits, the consultation meeting and the notice of layoff, if applicable, shall be served when the Employee has provided notice of readiness to return to work.
Consultation Process. (i) In the event the Trustees are required to consult with the Legal Representative pursuant to Section 2.2(e) above or on any other matters specified herein, the Trustees shall provide the Legal Representative with written advance notice of the matter under consideration and with as much relevant information concerning the matter as is reasonably practicable under the circumstances, subject to reasonable claims of privilege. The Trustees shall also provide the Legal Representative with such reasonable access to experts retained by the PI Trust and its staff (if any) as the Legal Representative may reasonably request during the time that the Trustees are considering such matter, and shall also provide the Legal Representative the opportunity, at reasonable times and for reasonable periods of time, to discuss and comment on such matter with the Trustees.
(ii) The Trustees shall take into consideration the time required for the Legal Representative, if he or she so wishes, to engage and consult with its own independent financial or investment advisors as to such matter.
Consultation Process. 7.1 The patient should attend the pharmacy in person to receive a consultation and if appropriate a supply of medication, in the same way they would be required to attend a GP appointment for a prescription. There may be exceptions to this and pharmacists are asked to exercise their professional judgment in deciding if a supply should be made in the absence of the patient.
7.2 The pharmacist should carry out a professional consultation with reference to the minor ailment scheme formulary (appendix 3). This will involve:
a) Patient assessment.
b) Provision of advice.
c) Completion of Pharmoutcomes data collection.
d) Supply of medication from the agreed formulary when appropriate.
7.3 The pharmacist should keep the consultation process as confidential as possible.
7.4 All patients being treated under the terms of the MAS must first be registered using the appropriate Pharmoutcomes service.
